Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Share-based Compensation (2013 - 2026)

Scynexis' (SCYX) quarterly Share-based Compensation came in at $600000.0 in Q2 2026, down 83.63% on a YoY basis from $3.7 million in Q2 2025, and down 82.95% quarter-over-quarter from $3.5 million in Q1 2026.

Analysis

Scynexis (SCYX) Share-based Compensation (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Share-based Compensation for 14 consecutive years, with $600000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation fell 83.63% year-over-year to $600000.0; the trailing twelve-month figure through Jun 2026 stood at $2.8 million (down 24.42% YoY), and the FY2025 full-year result was $2.9 million, down 13.33% from the prior year.
  • Share-based Compensation slipped to $600000.0 in Q2 2026 per SCYX's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $3.7 million in Q2 2025 and bottomed at $454000.0 in Q4 2022.
  • Historically, Share-based Compensation has averaged $2.0 million across 5 years, with a median of $2.0 million in 2023.
  • The widest YoY moves for Share-based Compensation: up 254.17% in 2022, down 87.63% in 2022.
  • Over 5 years, Share-based Compensation stood at $454000.0 in 2022, then rose by 15.42% to $524000.0 in 2023, then jumped by 80.53% to $946000.0 in 2024, then decreased by 26.0% to $700000.0 in 2025, then dropped by 14.29% to $600000.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $600000.0, $3.5 million, and $700000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 83.34 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 600,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600,000.00
Mar 31, 2026 3.52 Mn
Dec 31, 2025 700,000.00
Sep 30, 2025 3.63 Mn
Jun 30, 2025 3.66 Mn
Mar 31, 2025 3.54 Mn
Dec 31, 2024 946,000.00
Sep 30, 2024 2.91 Mn
Jun 30, 2024 2.84 Mn
Mar 31, 2024 2.72 Mn
Dec 31, 2023 524,000.00
Sep 30, 2023 1.96 Mn
Jun 30, 2023 1.97 Mn
Mar 31, 2023 1.96 Mn
Dec 31, 2022 454,000.00
Sep 30, 2022 2.13 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 922,000.00
Sep 30, 2021 600,000.00
Jun 30, 2021 542,000.00